Pharmaceutical Information |
Drug Name |
Naftifine |
Drug ID |
BADD_D01517 |
Description |
Naftifine is a synthetic, broad spectrum, antifungal agent and allylamine derivative for the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum. |
Indications and Usage |
For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum. |
Marketing Status |
approved |
ATC Code |
D01AE22 |
DrugBank ID |
DB00735
|
KEGG ID |
D08245
|
MeSH ID |
C029178
|
PubChem ID |
47641
|
TTD Drug ID |
D00HPK
|
NDC Product Code |
Not Available |
UNII |
4FB1TON47A
|
Synonyms |
naftifine | naftifin | naftifine hydrochloride, (E)-isomer | naftifine hydrochloride | N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride |
|
Chemical Information |
Molecular Formula |
C21H21N |
CAS Registry Number |
65472-88-0 |
SMILES |
CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32 |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|